Table 3 

Pneumococcal IgG types 18C and 23F  Comparisons between ResistAid^{(TM) }and Placebo Groups 

Day 0 Mean ± SD 
Day 51 Mean ± SD 
Day 72 Mean ± SD 
Change Day 051 
Change Day 072 



Type 18C 



ResistAid™ (n = 21) 
1.49 ± 3.00 
9.57 ± 7.96 
9.10 ± 7.53 
8.08 ± 7.12 
7.61 ± 6.81 


Placebo (n = 24) 
0.72 ± 1.35 
5.06 ± 5.80 
4.93 ± 5.26 
4.34 ± 5.10 
4.22 ± 4.69 


Comparison (pvalue) 
0.061 
0.006 
0.008 
0.033 
0.012 


Type 23F 



ResistAid™ (n = 21) 
0.74 ± 0.93 
7.07 ± 7.41 
7.02 ± 7.31 
6.33 ± 7.36 
6.28 ± 7.17 


Placebo (n = 24) 
1.08 ± 1.87 
4.32 ± 4.62 
4.55 ± 5.23 
3.24 ± 4.28 
3.46 ± 4.24 


Comparison (pvalue) 
0.059 
0.002 
0.041 
0.001 
0.003 


Levels of antibody subtypes 18C and 23F in the ResistAid™ and placebo groups are given as means (μg/dl) ± standard deviations on Days 0, 51 and 72 and changes from Day 0. Inoculation with the 23valent pneumococcal vaccine took place on Day 30. Pvalues are comparisons between groups and comparisons of changes from Day 0 in the two groups. 

Udani et al. Nutrition Journal 2010 9:32 doi:10.1186/14752891932 